List view / Grid view
1 June 2015 | By Victoria White
Roche has announced new results from the Phase II NeoSphere study that assessed a Perjeta regimen in people with HER2-positive early breast cancer...
1 June 2015 | By
Results from a trial of a new stem-cell based therapy for a rare skin condition, recessive dystrophic epidermolysis bullosa (RDEB), have been published...
1 June 2015 | By Victoria White
Results from a Phase 3 study demonstrate that palbociclib significantly extended progression-free survival in women with HR+HER2- metastatic breast cancer...
1 June 2015 | By Victoria White
BMS has announced positive results of a Phase III trial evaluating the Opdivo+Yervoy regimen in patients with previously untreated advanced melanoma...
29 May 2015 | By Victoria White
Gilead’s MAA for a fixed-dose combination of emtricitabine and tenofovir alafenamide (F/TAF) has been fully validated and is now under evaluation by the EMA..
29 May 2015 | By VIctoria White
Janssen and Bayer have launched a clinical research programme evaluating rivaroxaban for the prevention and treatment of blood clots in patients with cancer...
28 May 2015 | By Victoria White
Synjardy has been granted marketing authorisation by the European Commission for the treatment of adults with type 2 diabetes (T2D) in the European Union...
28 May 2015 | By Victoria White
Johnson & Johnson has accepted the 1 March 2015 binding offer from Cardinal Health to acquire its Cordis business for an approximate value of $2 billion...
28 May 2015 | By Victoria White
Seres Therapeutics has enrolled and dosed the first patient in its Phase 2 clinical study of SER-109 in recurrent CDI in adults...
28 May 2015 | By Victoria White
ESMO, in collaboration with EORTC, have expressed their views on the EU Clinical Trials Regulation in an official position paper...
28 May 2015 | By Victoria White
Pfizer has announced initial results of its global NarRAtive survey of more than 3,600 adults with rheumatoid arthritis in 13 countries...
28 May 2015 | By Victoria White
Top line results have been announced from the GS-4774 Phase 2 study in patients with HBV on long term viral suppression with an oral antiviral treatment...
28 May 2015 | By Victoria White
A trial has found that HIV-infected individuals have a lower risk of developing AIDS or other serious illnesses if given antiretroviral drugs sooner...
28 May 2015 | By TA Instruments
TA Instruments announced the acquisition of certain assets related to the Bose ElectroForce Group, from the Bose Corporation of Framingham Massachusetts...
28 May 2015 | By Victoria White
The US Food and Drug Administration has approved Boehringer Ingelheim’s once-daily Stiolto Respimat (tiotropium bromide and olodaterol) Inhalation Spray...
